CME
Optimizing the Use of Immunotherapy in the First-line Maintenance Setting for Metastatic Urothelial Carcinoma
July 19, 2023
Guest: Petros Grivas, MD, PhD Guest: Thomas Powles, MD, PhD Survival for patients with metastatic urothelial cancer has increased with the approval of immune therapy, antibody-drug conjugates, and targeted agents. In the maintenance setting,
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!